Your session is about to expire
← Back to Search
Behavioral Intervention
Preventing Drug Abuse Among Sexual Minority Youth
N/A
Waitlist Available
Led By Traci M. Schwinn, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-year follow-up
Summary
This trial tests an online program aimed at preventing drug use among teenagers who identify as sexual minorities. The program offers engaging sessions with useful information and support to help these youths avoid drugs.
Who is the study for?
This trial is for teenagers aged 15-17 in the U.S. who identify as gay, lesbian, bisexual, or unsure of their sexual orientation and can speak and read English. They must have private access to a desktop, laptop, or tablet with internet.
What is being tested?
The study is testing 'Free2b', a web-based drug abuse prevention program tailored for young sexual minority individuals against an attention-placebo control to see its effectiveness over time.
What are the potential side effects?
Since this intervention involves educational content rather than medication, traditional side effects are not expected; however, participants may experience emotional discomfort discussing sensitive topics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-year follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-year follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of times youth binge drank in the past month
Number of times youth drank alcohol in the past month
Number of times youth smoked cigarettes in the past month
+3 moreSecondary study objectives
Mean scores for Assertiveness
Mean scores for Consequences of Substance Use
Mean scores for Coping
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
9 sessions and website with entertainment features and resources
Group II: ControlPlacebo Group1 Intervention
website with entertainment features and resources
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Free2b
2020
N/A
~1220
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Behavioral interventions, such as Cognitive Behavioral Therapy (CBT), Motivational Interviewing (MI), and Contingency Management (CM), are designed to modify the patient's behavior and thought patterns related to substance use. CBT helps patients recognize and change maladaptive thoughts and behaviors, MI enhances intrinsic motivation to change by resolving ambivalence, and CM uses positive reinforcement to encourage abstinence.
These mechanisms are crucial for substance abuse patients as they address the psychological and behavioral aspects of addiction, promoting long-term recovery and reducing the likelihood of relapse.
A Process Evaluation of a Substance Use Brief Intervention for Adolescents in a Psychiatric Inpatient Program.Web-based interventions for substance use disorders: a qualitative review.
A Process Evaluation of a Substance Use Brief Intervention for Adolescents in a Psychiatric Inpatient Program.Web-based interventions for substance use disorders: a qualitative review.
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,492 Previous Clinical Trials
2,663,642 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,594 Previous Clinical Trials
3,327,520 Total Patients Enrolled
Traci M. Schwinn, PhDPrincipal InvestigatorColumbia University